Nuvectis Pharma, Inc. — Director's Dealing 2025

Jun 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2025-06-12

Reporting Person: Oliviero James F III (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-12	Common Stock	A	30000	—	Acquired	87828	Direct

Footnotes

F1: The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Oliviero's continued service on the Company's Board of Directors on such dates.